GQG.ASX VYS.ASX BOT.ASX AVH.ASX KAL.ASX

Smooth and Engaging News Roundup

GQG Partners Delivers Solid 2025 Results

GQG Partners Inc. had a strong year in 2025, reporting impressive growth across key metrics. The company's funds under management (FUM) reached a record $163.9 billion, up 7.1% from 2024, driven by solid investment performance. Net revenue increased 6.3% to $808.3 million, while net income rose 7.3% to $463.3 million.

The company's four core investment strategies - Global Equity, International Equity, Emerging Markets Equity, and US Equity - all outperformed their respective benchmarks since inception, showcasing GQG's ability to navigate volatile markets. GQG's focus on protecting client capital and investing in high-quality companies has served the firm well through various market cycles.

Looking ahead, GQG remains well-diversified across its strategies and distribution channels, with an average fee realization of 48.4 basis points, making the company less susceptible to margin pressure compared to peers. The board has declared a fourth-quarter dividend of $0.0365 per share, representing a 90% payout ratio of distributable earnings.

Vysarn and Kariyarra Partner on Water Scheme

Vysarn Ltd announced that the Kariyarra Aboriginal Corporation has formally submitted a detailed hydrogeological assessment for the Kariyarra Water Scheme, which is part of a joint venture between Vysarn and the Kariyarra people to develop water resources in the Pilbara region.

The H3 Report, prepared by Vysarn's subsidiary Pentium Water, supports the Kariyarra's application for a groundwater license of up to 10 GL per annum over 30 years. This license will form part of the binding joint venture to investigate, assess, manage, own, extract, and supply water from identified and secured resources on Kariyarra country.

Vysarn's wholly owned subsidiary, Vysarn Asset Management, has continued to advance commercial discussions with potential bulk water off-takers in the East Pilbara region and has lodged a Registration of Interest with the Water Corporation to be a prospective supplier of bulk water to Port Hedland.

Botanix Pauses Trading, Potential Capital Raise

Botanix Pharmaceuticals Ltd has requested a trading halt of its securities pending the release of an announcement regarding a potential capital raising. The trading halt will remain in place until the earlier of the announcement's release or the market open on 17 February 2026.

The company has not provided any further details on the reason for the trading halt or the potential capital raise. Investors will have to wait for the upcoming announcement to get more clarity on Botanix's plans.

KalGold Uncovers Thick Gold Intercepts at Pinjin

Kalgoorlie Gold Mining Ltd (KalGold) reported exciting results from its first diamond drilling program at the Kirgella Gift and Providence deposits within the Pinjin Project. The drilling program uncovered broad zones of gold anomalism and mineralization, with intercepts extending to a depth of 300 meters, deeper than previous drilling.

KalGold has identified new targets for follow-up drilling to test the vertical continuity and potential repetition of the high-grade gold mineralization. The company plans to undertake further RC and aircore drilling programs across the broader Pinjin Project area to continue defining the extent of gold mineralization.

AVITA Stabilizes Business, Positions for Growth

AVITA Medical reported its Q4 and full-year 2025 financial results, highlighting a more stable revenue performance and improved visibility across its account utilization. The company exited 2025 with reimbursement clarity and early signs of utilization normalizing across its core burn and trauma centers.

AVITA has also advanced its post-market clinical programs for Cohealyx and PermeaDerm, with data expected in 2026. To support its long-term growth, the company has secured a new $60 million credit facility with Perceptive Advisors, which will strengthen its capital structure.

Looking ahead, AVITA provided 2026 net revenue guidance of $80 to $85 million, representing 12% to 19% growth compared to 2025. The company is focused on disciplined cash management, sharpening execution, and accelerating commercial momentum across its core U.S. market.